Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 12/2018

16.07.2018 | Original paper

Assessment of left atrial function using speckle tracking echocardiography in ankylosing spondylitis: a case-control study

verfasst von: Murathan Kucuk, Necmettin Korucuk, Veysel Tosun, Mediha Cavusoglu, İbrahim Basarici

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to assess the left atrium (LA) deformation parameters by using 2D speckle tracking echocardiography (2D-STE) in ankylosing spondylitis (AS) patients and to evaluate the relationship between these parameters and AS clinical indexes. 30 patients with AS (22 males, 8 females) and 30 healthy individuals (19 males, 11 females) were enrolled in this study. Transthoracic echocardiography was performed to both groups. Besides the conventional echocardiographic parameters, the LA strain parameters; including systolic-reservoir (LA S-S), early diastolic-conduit (LA S-E), late diastolic-contraction (LA S-A) were measured. No significant difference was found between two groups in terms of conventional echocardiographic parameters except mean deceleration time (DT). Mean DT was prolonged in the AS patients compare with the control group (173.5 ± 22.5 vs. 155.3 ± 36.7, p = 0.025). In the AS patients, LA S-S (48.3 ± 9.4 vs. 56.9 ± 10.1, p = 0.001), LA S-E (26.4 ± 6.4 vs. 31.6 ± 7.3, p = 0.005) and LA S-A (21.9 ± 4.7 vs. 25.4 ± 5.7, p = 0.013) values were statistically lower than the control group. Also a negative correlation was observed between the Bath Ankylosing Spondylitis Metrology Index (BASMI) and LA S-S (r = − 0.509, p = 0.004), LA S-E (r = − 0.501, p = 0.005). Our study demonstrated that 2D-STE is a useful method to determine the left atrial involvement in AS patients without the clinical evident of cardiovascular disease.
Literatur
1.
Zurück zum Zitat Lehtinen K (1993) Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 52:174–176CrossRef Lehtinen K (1993) Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 52:174–176CrossRef
2.
Zurück zum Zitat Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61:iii8–iii18CrossRef Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61:iii8–iii18CrossRef
3.
Zurück zum Zitat Lautermann D, Braun J (2002) Ankylosing spondylitis-cardiac manifestations. Clin Exp Rheumatol 20:11–15 Lautermann D, Braun J (2002) Ankylosing spondylitis-cardiac manifestations. Clin Exp Rheumatol 20:11–15
4.
Zurück zum Zitat Ustun N, Kurt M, Nacar AB, Karateke HP, Guler H, Turhanoglu AD (2015) Left ventricular systolic dysfunction in patients with ankylosing spondylitis without clinically overt cardiovascular disease by speckle tracking echocardiography. Rheumatol Int 35:607–611CrossRef Ustun N, Kurt M, Nacar AB, Karateke HP, Guler H, Turhanoglu AD (2015) Left ventricular systolic dysfunction in patients with ankylosing spondylitis without clinically overt cardiovascular disease by speckle tracking echocardiography. Rheumatol Int 35:607–611CrossRef
5.
Zurück zum Zitat Crowley JJ, Donnelly SM, Tobin M, FitzGerald O, Bresnihan B, Maurer BJ et al (1993) Doppler echocardiographic evidence of left ventricular diastolic dysfunction in ankylosing spondylitis. Am J Cardiol 71:1337–1340CrossRef Crowley JJ, Donnelly SM, Tobin M, FitzGerald O, Bresnihan B, Maurer BJ et al (1993) Doppler echocardiographic evidence of left ventricular diastolic dysfunction in ankylosing spondylitis. Am J Cardiol 71:1337–1340CrossRef
6.
Zurück zum Zitat Brewerton DA, Gibson DG, Goddard DH, Jones TJ, Moore RB, Pease CT et al (1987) The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet 1:995–998CrossRef Brewerton DA, Gibson DG, Goddard DH, Jones TJ, Moore RB, Pease CT et al (1987) The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet 1:995–998CrossRef
7.
Zurück zum Zitat Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ (1992) Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis 51:227–232CrossRef Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ (1992) Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis 51:227–232CrossRef
8.
Zurück zum Zitat Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G et al (2011) Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 24:277–313CrossRef Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G et al (2011) Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 24:277–313CrossRef
9.
Zurück zum Zitat Altekin RE, Yanikoglu A, Karakas MS, Ozel D, Kucuk M, Yilmaz H et al (2012) Assessment of left atrial dysfunction in obstructive sleep apnea patients with the two dimensional speckle-tracking echocardiography. Clin Res Cardiol 101:403–413CrossRef Altekin RE, Yanikoglu A, Karakas MS, Ozel D, Kucuk M, Yilmaz H et al (2012) Assessment of left atrial dysfunction in obstructive sleep apnea patients with the two dimensional speckle-tracking echocardiography. Clin Res Cardiol 101:403–413CrossRef
10.
Zurück zum Zitat Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of spondylo arthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783CrossRef Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of spondylo arthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783CrossRef
11.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
12.
Zurück zum Zitat Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
13.
Zurück zum Zitat Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694–1698PubMed Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694–1698PubMed
14.
Zurück zum Zitat Roman MJ, Salmon JE (2007) Cardiovascular manifestations of rheumatologic diseases. Circulation 116:2346–2355CrossRef Roman MJ, Salmon JE (2007) Cardiovascular manifestations of rheumatologic diseases. Circulation 116:2346–2355CrossRef
15.
Zurück zum Zitat Moyssakis I, Gialafos E, Vassiliou VA, Boki K, Votteas V, Sfikakis PP et al (2009) Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol 38:216–221CrossRef Moyssakis I, Gialafos E, Vassiliou VA, Boki K, Votteas V, Sfikakis PP et al (2009) Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol 38:216–221CrossRef
16.
Zurück zum Zitat O’Neill TW, Bresnihan B (1992) The heart in ankylosing spondylitis. Ann Rheum Dis 51:705–706CrossRef O’Neill TW, Bresnihan B (1992) The heart in ankylosing spondylitis. Ann Rheum Dis 51:705–706CrossRef
17.
Zurück zum Zitat Kvalvik AG, Jones MA, Symmons DP (2000) Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol 29:29–37CrossRef Kvalvik AG, Jones MA, Symmons DP (2000) Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol 29:29–37CrossRef
18.
Zurück zum Zitat Prior P, Symmons DP, Scott DL, Brown R, Hawkins CF (1984) Cause of death in rheumatoid arthritis. Br J Rheumatol 23:92–99CrossRef Prior P, Symmons DP, Scott DL, Brown R, Hawkins CF (1984) Cause of death in rheumatoid arthritis. Br J Rheumatol 23:92–99CrossRef
19.
Zurück zum Zitat Goodson NJ, Wiles NJ, Lunt M, Barret EM, Silman AJ, Symmons DP (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46:2010–2019CrossRef Goodson NJ, Wiles NJ, Lunt M, Barret EM, Silman AJ, Symmons DP (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46:2010–2019CrossRef
20.
Zurück zum Zitat Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387–389CrossRef Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387–389CrossRef
21.
Zurück zum Zitat Hirota H, Yoshida K, Kishimoto T, Taga T (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92:4862–4866CrossRef Hirota H, Yoshida K, Kishimoto T, Taga T (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92:4862–4866CrossRef
22.
Zurück zum Zitat Di Salvo G, Caso P, Lo Piccolo R, Fusco A, Martiniello AR, Russo MG et al (2005) Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation 112:387–395CrossRef Di Salvo G, Caso P, Lo Piccolo R, Fusco A, Martiniello AR, Russo MG et al (2005) Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation 112:387–395CrossRef
23.
Zurück zum Zitat Stefanadis C, Dernellis J, Toutouzas P (2001) A clinical appraisal of left atrial function. Eur Heart J 22:22–36CrossRef Stefanadis C, Dernellis J, Toutouzas P (2001) A clinical appraisal of left atrial function. Eur Heart J 22:22–36CrossRef
24.
Zurück zum Zitat Chen Y, Chung HY, Zhao CT, Wong A, Zhen Z, Tsang HH et al (2015) Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatology 54:292–301CrossRef Chen Y, Chung HY, Zhao CT, Wong A, Zhen Z, Tsang HH et al (2015) Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatology 54:292–301CrossRef
25.
Zurück zum Zitat Acar G, Sayarlioglu M, Akcay A, Sokmen A, Sokmen G, Altun B et al (2009) Assessment of atrial electromechanical coupling characteristics in patients with ankylosing spondylitis. Echocardiography 26:549–557CrossRef Acar G, Sayarlioglu M, Akcay A, Sokmen A, Sokmen G, Altun B et al (2009) Assessment of atrial electromechanical coupling characteristics in patients with ankylosing spondylitis. Echocardiography 26:549–557CrossRef
Metadaten
Titel
Assessment of left atrial function using speckle tracking echocardiography in ankylosing spondylitis: a case-control study
verfasst von
Murathan Kucuk
Necmettin Korucuk
Veysel Tosun
Mediha Cavusoglu
İbrahim Basarici
Publikationsdatum
16.07.2018
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 12/2018
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-018-1411-4

Weitere Artikel der Ausgabe 12/2018

The International Journal of Cardiovascular Imaging 12/2018 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.